
WHY AFRICAN HERO?






Immediate Infrastructure Impact
​
​​
​
​
Financially Efficient
​​​
​
​​Reliable & Durable
​​​
​
​
Strengthened medical supply chain
​​​
​
​
Digitally Ready
​​​
​
​​Global Reporting Transparency
​
​​
​
​
​
-
Fast-tracked deployment compared to years-long government builds.
-
Delivers services immediately once operational.
-
Botswana partnership will create a SADC-wide manufacturing and distribution node, in association with the Government of Botswana and capital partners, stimulating African socio-economic development and trade.
​
​
​
​
-
Lease-to-own model eases government fiscal pressures.
-
Off-balance-sheet structure avoids upfront CapEx.
-
Predictable, long-term budgeting for governments and donors.
-
Flexible rental structures matched to government payment cycles.
-
​Each country’s African Hero operation is independently licensed and responsible for its own income, expenses, tax, and compliance obligations.
​
​
​
-
IPS prefabricated structures rated for long-term durability.
-
Low infrastructure requirements - fully operational even in areas with no utilities.
​
​
​
​
​
-
Full IT infrastructure enabling 4IR-ready education and telemedicine.
-
Internet access provided through Starlink and local networks.
​
​​​
​
-
Full reporting to investors, donors, and governments.
-
Data collection for predictive planning and sustainable development modelling.
-
African Hero’s data-driven model allows international donors, development organisations and multilaterals to deploy funds with full transparency, accountability, and trackable outcomes aligned to global development goals.
​
​
​
​
​
-
The Mediland medical solution provides an efficient distribution network that eliminates stock shortages, lifting national availability of vital drugs and medicines.
-
No-risk inventory management for governments, as the state only pays for medicines that reach end users.
-
Significantly enhanced value for medical supply budgets, freeing critical resources for other healthcare needs.
-
Greater profitability for GMs, substantial discounts for public health systems, and increased affordability and accessibility for patients.

